相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Iron-Chelation Treatment by Novel Thiosemicarbazone Targets Major Signaling Pathways in Neuroblastoma
Peter Macsek et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma
Matthew J. Kling et al.
BMC CANCER (2021)
Molecular Mechanisms of MYCN Dysregulation in Cancers
Ruochen Liu et al.
FRONTIERS IN ONCOLOGY (2021)
Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries
Xiaonan Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A small-molecule pan-class I glucose transporter inhibitor reduces cancer cell proliferation in vitro and tumor growth in vivo by targeting glucose-based metabolism
Pratik Shriwas et al.
CANCER & METABOLISM (2021)
The iron chelator Deferasirox causes severe mitochondrial swelling without depolarization due to a specific effect on inner membrane permeability
Esther M. Gottwald et al.
SCIENTIFIC REPORTS (2020)
Multiple Facets of Autophagy and the Emerging Role of Alkylphosphocholines as Autophagy Modulators
Ferda Kaleagasioglu et al.
FRONTIERS IN PHARMACOLOGY (2020)
Mitochondrial spare respiratory capacity: Mechanisms, regulation, and significance in non-transformed and cancer cells
Philippe Marchetti et al.
FASEB JOURNAL (2020)
Role of Oncogenes and Tumor-suppressor Genes in Carcinogenesis: A Review
Emmanuel N. Kontomanolis et al.
ANTICANCER RESEARCH (2020)
Establishment of 2D Cell Cultures Derived From 3D MCF-7 Spheroids Displaying a Doxorubicin Resistant Profile
Ana S. Nunes et al.
BIOTECHNOLOGY JOURNAL (2019)
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma
Sofie Mohlin et al.
EMBO MOLECULAR MEDICINE (2019)
A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma
Luca Montemurro et al.
CANCER RESEARCH (2019)
A phase I study of the safety and tolerability of VLX600, an Iron Chelator, in patients with refractory advanced solid tumors
Kabir Mody et al.
INVESTIGATIONAL NEW DRUGS (2019)
MYCN-enhanced Oxidative and Glycolytic Metabolism Reveals Vulnerabilities for Targeting Neuroblastoma
Ganna Oliynyk et al.
ISCIENCE (2019)
An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Jennifer R. Molina et al.
NATURE MEDICINE (2018)
Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer
Yonathan Lissanu Deribe et al.
NATURE MEDICINE (2018)
The Expanding World of N-MYC-Driven Tumors
David S. Rickman et al.
CANCER DISCOVERY (2018)
LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer
Liqin Du et al.
Oncotarget (2018)
The Role for Myc in Coordinating Glycolysis, Oxidative Phosphorylation, Glutaminolysis, and Fatty Acid Metabolism in Normal and Neoplastic Tissues
Eric S. Goetzman et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
MYC is downregulated by a mitochondrial checkpoint mechanism
Xiaonan Zhang et al.
ONCOTARGET (2017)
Data Descriptor: Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines
Jo Lynne Harenza et al.
SCIENTIFIC DATA (2017)
MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation
Kyung-Min Lee et al.
CELL METABOLISM (2017)
LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis
Shizhen Zhu et al.
CANCER CELL (2017)
MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins
Sarah E. Calvo et al.
NUCLEIC ACIDS RESEARCH (2016)
The Anticancer Agent, Di-2-Pyridylketone 4,4-Dimethyl-3-Thiosemicarbazone (Dp44mT), Up-Regulates the AMPK-Dependent Energy Homeostasis Pathway in Cancer Cells
Sukriti Krishan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Autophagy provides metabolic substrates to maintain energy charge and nucleotide pools in Ras-driven lung cancer cells
Jessie Yanxiang Guo et al.
GENES & DEVELOPMENT (2016)
Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors
Lynsey Vaughan et al.
ONCOTARGET (2016)
Iron chelators target both proliferating and quiescent cancer cells
Marten Fryknas et al.
SCIENTIFIC REPORTS (2016)
Cancer multicellular spheroids: Volume assessment from a single 2D projection
Filippo Piccinini et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2015)
Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing
Xue Gong et al.
PLOS ONE (2015)
Autophagy Inhibition Contributes to the Synergistic Interaction between EGCG and Doxorubicin to Kill the Hepatoma Hep3B Cells
Li Chen et al.
PLOS ONE (2014)
Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments
Xiaonan Zhang et al.
NATURE COMMUNICATIONS (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
Alexandre Puissant et al.
CANCER DISCOVERY (2013)
Neuroblastoma and MYCN
Miller Huang et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
c-Myc and Cancer Metabolism
Donald M. Miller et al.
CLINICAL CANCER RESEARCH (2012)
The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer
Niranjan Awasthi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Mitochondrial Structure, Function and Dynamics Are Temporally Controlled by c-Myc
J. Anthony Graves et al.
PLOS ONE (2012)
Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)
Jie Zheng
ONCOLOGY LETTERS (2012)
Antitumor Activity of Metal-Chelating Compound Dp44mT Is Mediated by Formation of a Redox-Active Copper Complex That Accumulates in Lysosomes
David B. Lovejoy et al.
CANCER RESEARCH (2011)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Quantitative Microplate-Based Respirometry with Correction for Oxygen Diffusion
Akos A. Gerencser et al.
ANALYTICAL CHEMISTRY (2009)
MYC - TIMELINE Reflecting on 25 years with MYC
Natalie Meyer et al.
NATURE REVIEWS CANCER (2008)
The mTOR pathway in the control of protein synthesis
Xuemin Wang et al.
PHYSIOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
LC3 conjugation system in mammalian autophagy
I Tanida et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
The requirement for evasion of programmed cell death in neuroblastomas with MYCN amplification
MD Hogarty
CANCER LETTERS (2003)
N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation
PS Knoepfler et al.
GENES & DEVELOPMENT (2002)
c-Myc regulates mammalian body size by controlling cell number but not cell size
A Trumpp et al.
NATURE (2001)
分享论文
